Meissa Vaccines Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Liquidation

Meissa Vaccines General Information

Description

Developer of a pediatric vaccine designed to protect people from deadly respiratory viruses. The company's vaccines are made for the respiratory syncytial virus (RSV) and rhinovirus (HRV) having widespread benefits for society and families that include reducing the burden of acute lower respiratory tract disease, reducing colds and reducing acute asthma exacerbations caused by viruses, enabling consumers to protect their children from viral infections resulting in alleviating missed school and work.

Contact Information

Website
www.meissavaccines.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • JLABS, 329 Oyster Point Boulevard
  • 3rd Floor
  • San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • JLABS, 329 Oyster Point Boulevard
  • 3rd Floor
  • San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Meissa Vaccines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 12-Jun-2024 Completed Bankruptcy: Liquidation
5. Later Stage VC (Series A) 02-Oct-2019 Completed Pre-Clinical Trials
4. Seed Round 27-Mar-2019 Completed Pre-Clinical Trials
3. Grant 31-Jan-2018 Completed Pre-Clinical Trials
2. Seed Round 03-Aug-2017 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Meissa Vaccines’s complete valuation and funding history, request access »

Meissa Vaccines Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Meissa Vaccines’s complete cap table history, request access »

Meissa Vaccines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pediatric vaccine designed to protect people from deadly respiratory viruses. The company's vaccines are
Drug Discovery
San Francisco, CA
17 As of 2023

Farmington, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Meissa Vaccines Competitors (1)

One of Meissa Vaccines’s competitors is CaroGen, a Venture Capital-Backed company based in Farmington, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CaroGen Venture Capital-Backed Farmington, CT
You’re viewing 1 of 1 competitors. Get the full list »

Meissa Vaccines Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Meissa Vaccines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240082385-A1 Rsv vaccines and methods of administering same Inactive 27-May-2022
WO-2023092100-A2 Methods of administering chimeric vaccines Inactive 19-Nov-2021
WO-2023092100-A3 Methods of administering chimeric vaccines Inactive 19-Nov-2021
JP-2023530445-A Chimeric rsv and coronavirus proteins, immunogenic compositions and methods of use Pending 17-Jun-2020
AU-2021292397-A1 Chimeric rsv and coronavirus proteins, immunogenic compositions, and methods of use Inactive 17-Jun-2020 A61K39/12
To view Meissa Vaccines’s complete patent history, request access »

Meissa Vaccines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Meissa Vaccines FAQs

  • When was Meissa Vaccines founded?

    Meissa Vaccines was founded in 2014.

  • Where is Meissa Vaccines headquartered?

    Meissa Vaccines is headquartered in San Francisco, CA.

  • What is the size of Meissa Vaccines?

    Meissa Vaccines has 17 total employees.

  • What industry is Meissa Vaccines in?

    Meissa Vaccines’s primary industry is Drug Discovery.

  • Is Meissa Vaccines a private or public company?

    Meissa Vaccines is a Private company.

  • What is Meissa Vaccines’s current revenue?

    The current revenue for Meissa Vaccines is .

  • How much funding has Meissa Vaccines raised over time?

    Meissa Vaccines has raised $33.4M.

  • Who are Meissa Vaccines’s competitors?

    CaroGen is a competitor of Meissa Vaccines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process